Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

North Korea, Harvey Can't Keep The Market Down

Published 08/29/2017, 09:15 PM
Updated 07/09/2023, 06:31 AM

The September episode of the Zacks Ultimate Strategy Session will be available for viewing no later than Thursday, September 7th. Sheraz Mian, David Bartosiak, Tracey Ryniec, Neena Mishra, CFA, FRM, and Brian Bolan will cover the investment landscape from most every angle in this popular event.

Don't miss your chance to hear:

• David and Brian Agree to Disagree on whether investing in Chinese stocks is a good or bad idea
• Sheraz and Neena choose one portfolio to give feedback for improvement
• And much more

Remember, we need your input. Please submit your portfolio for the Portfolio Makeover segment by Thursday morning, August 31st. Email now to mailbag@zacks.com.

Then log on to Zacks.com and bookmark this page.


If Hurricane Harvey couldn’t rattle the market on Monday, then North Korea’s latest missile test wasn’t going to do it on Tuesday. Stocks actually opened the session sharply lower on news that the latest test flew over part of Japan. However, as the day wore on and worries subsided, the major indices were able to mount a rebound that left all three on the positive side by the closing bell.

The S&P advanced 0.08% to 2446.3, while the Dow increased 0.26% to 21,865.4. The NASDAQ performed the best with a rise of 0.30% to 6301.9.

“The market seems to be in a react first and ask questions later mode when it comes to North Korea,” said Eric in Surprise Trader. “Any possible escalation is immediately sold-off, but as it turns out to be yet another false alarm, things cool down and get back to normal again. I’d expect this sort of trend to continue in the near-term.”

The portfolios sprung back into action today with Home Run Investor, Stocks Under $10 and Short List all making additions. Meanwhile, Healthcare Innovators had a huge winner today as Kevin decided it was time to take profits on one of the portfolio’s best performers. The highlights section below has more on all these buys.

Today's Portfolio Highlights:

Healthcare Innovators: As mentioned here often (including yesterday), Juno Therapeutics (JUNO) has been a big winner for the portfolio. The company was one of the inaugural picks of this service back in April, and it has since been among the top movers numerous times. After another double-digit surge today lifted the stock to within striking distance of his price objective, Kevin felt it was finally time to cash in. The editor sold JUNO on Tuesday for an impressive 70% return in approximately 4 months.

Home Run Investor: The health insurance business is “making big bucks”, and Dave wants a piece of the action to further diversify and insulate the portfolio from its tech risk. Therefore, the editor bought Health Insurance Innovations (HIIQ), a developer and administrator of web-based individual health insurance plans and ancillary products. This Zacks Rank #1 (Strong Buy) has “tremendous” revenue and EPS growth, which has led to a string of positive earnings estimate revisions over the past year. Read the complete commentary for more on this new addition.

Stocks Under $10: Recent indications suggest a sector rotation into solar names, so Brian wants to get some exposure to the space. Today he added Vivint Solar (VSLR), a Zacks Rank #2 (Buy) provider of residential solar energy systems. The company is still losing money for now, but its recent quarter included an earnings beat and a huge lift in revenue. In fact, VSLR has strung together four straight quarters of positive earnings surprises and sequential revenue growth, which has the editor thinking that “the growth is ready to break out”. Read more about this new addition in the full write-up, and get ready for another buy tomorrow.

Zacks Short List: This week, the portfolio short-covered ConocoPhillips (NYSE:COP, +2%) and GoDaddy (GDDY). The two new buys that replaced these names are Jd.com (JD) and Occidental Petroleum (NYSE:OXY). Learn more about this emotion-free portfolio that takes advantage of falling and volatile markets by reading the Short List Trader Guide.

Counterstrike: "Well today, we officially stumbled across the “Bizarro Market”. If you didn’t follow the last 24 hours, you might look at the latest news and think there is a lot of trouble out there. A major U.S. city is under water and North Korea is shooting missiles over Japan. Time to sell stocks right?

"Well today was evidence that the market doesn’t care about either of those events. After a gap down of about 0.75%, the slow grind higher today was a resilient enough sign that the market doesn’t believe that a North Korea event will happen. In addition, the market thinks that the cleanup and rebuilding of Houston will help the economy more than hurt it.

"The S&P continues to just hang out around 2440. That level is a magnet for some reason and until there is some concrete reason for participants to either buy or sell the market, we will remain stuck." -- Jeremy Mullin

Have a Good Evening,
Jim Giaquinto

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Recommendations from Zacks' Private Portfolios:

Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks' private recommendation services. If you would like to follow our Buy and Sell signals in real time, we've made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks' portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we've predicted with an astonishing 80%+ accuracy). Click here to "test drive" Zacks Ultimate for FREE >>


Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.